1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
Sydnee Gatewood
Sydnee Gatewood
Articles (2204) 

Mario Gabelli Comments on Johnson & Johnson

Guru stock highlight

May 29, 2020 | About:
Johnson & Johnson (0.3%) (NYSE:JNJ) (JNJ – $131.13 – NYSE) is the world’s largest and most diversified healthcare company. The company’s pharmaceutical business is one of the fastest growing in the industry, driven by multiple new oncology products and anti-inflammatory products. The consumer division is recovering after several years of manufacturing and quality problems, but it must continue to innovate and reformulate its products to meet consumer demands for natural and organic products. While the medical device business had been improving in recent quarters, it will be significantly impacted by the delay in elective surgeries during the Coronavirus outbreak. Johnson & Johnson has the management team and the strong balance sheet to emerge from the current crisis in a stronger position than ever before.

From Mario Gabelli (Trades, Portfolio)'s Gabelli Asset Fund first-quarter 2020 shareholder commentary.

About the author:

Sydnee Gatewood
I am the editorial director at GuruFocus. I have a BA in journalism and a MA in mass communications from Texas Tech University. I have lived in Texas most of my life, but also have roots in New Mexico and Colorado. Follow me on Twitter! @gurusydneerg

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by Sydnee Gatewood


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)